The FDA Approves Weight Loss Drug Zepbound, a Wegovy and Ozempic Rival
Publisher |
WIRED
Media Type |
audio
Categories Via RSS |
Science
Publication Date |
Nov 10, 2023
Episode Duration |
00:04:53

Eli Lilly is about to release Zepbound, a new entrant in the superheated competition for blockbuster weight loss drugs.

Read this story here.

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review